SCHEMBL24601398

SCHEMBL24601398

CC(C)(c1ccccc1)c1ccc2c3c4c5ccc(C(C)(C)c6ccccc6)cc5n5c6cc(C(C)(C)c7ccccc7)ccc6c(c6c7ccc(C(C)(C)c8ccccc8)cc7n(c2c1)c36)c45

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.43
ESR2 Q92731 5/20 0.43
CYP3A4 P08684 2/20 0.43
ALDH1A1 P00352 1/20 0.43
NR3C2 P08235 3/20 0.39
CNR1 P21554 4/20 0.38
CNR2 P34972 4/20 0.38
KIF11 P52732 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
AR P10275 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
HTR6 P50406 1/20 0.31
ESRRG P62508 1/20 0.31
SLC6A3 Q01959 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601400 0.94 ESR1 (0.39) ESR1ESR2CYP3A4ALDH1A1NR3C2
SCHEMBL24601397 0.91 CNR1 (0.38) ESR1ESR2CYP3A4ALDH1A1NR3C2
SCHEMBL24601515 0.89 HSD17B2 (0.35) ESR1ESR2CYP3A4ALDH1A1NR3C2
SCHEMBL24601422 0.87 RXRA (0.38) ESR1ESR2CYP3A4ALDH1A1NR3C2
SCHEMBL24601403 0.87 ESR1 (0.43) ESR1ESR2CYP3A4ALDH1A1NR3C2
SCHEMBL24601516 0.87 RXRB (0.35) ESR1ESR2CYP3A4ALDH1A1NR3C2
SCHEMBL24601402 0.86 HSD17B2 (0.38) ESR1ESR2CYP3A4ALDH1A1CNR1
SCHEMBL24601399 0.86 ESR1 (0.40) ESR1ESR2CYP3A4ALDH1A1NR3C2
SCHEMBL24601428 0.85 ESR1 (0.37) ESR1ESR2CYP3A4ALDH1A1NR3C2
SCHEMBL24601625 0.84 KIF11 (0.38) ESR1ESR2CYP3A4ALDH1A1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 ESR1 1037/4885ESR2 2012/4885CYP3A4 4411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.